Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
everolimus (zortress) (1 trial)
sirolimus (rapamune) (1 trial)
Colorectal Neoplasms (Phase 2)
Hamartoma (Phase 2)
Hamartoma Syndrome, Multiple (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasms (Phase 2)
Syndrome (Phase 2)
Trials (2 total)
Trial APIs (2 total)